Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.

Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G, Hsieh JC, Hofstaedter F, Hartmann A, Knuechel R, Rosenthal A, Pilarsky C.

J Pathol. 2003 Oct;201(2):204-12.

PMID:
14517837
2.

Dysregulation of Wnt pathway components in human salivary gland tumors.

Queimado L, Obeso D, Hatfield MD, Yang Y, Thompson DM, Reis AM.

Arch Otolaryngol Head Neck Surg. 2008 Jan;134(1):94-101. doi: 10.1001/archotol.134.1.94.

PMID:
18209144
3.

Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.

Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD.

Carcinogenesis. 2006 Jul;27(7):1341-8. Epub 2006 Feb 25.

PMID:
16501252
4.

Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.

An G, Ng AY, Meka CS, Luo G, Bright SP, Cazares L, Wright GL Jr, Veltri RW.

Cancer Res. 2000 Dec 15;60(24):7014-20.

5.

Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.

Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.

J Pathol. 2003 Oct;201(2):268-77.

PMID:
14517844
6.

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.

PMID:
16007117
7.

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

8.

A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.

Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.

J Natl Cancer Inst. 2006 Jun 21;98(12):825-38.

PMID:
16788156
9.

Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.

Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2109-16.

10.

Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma.

Milovanovic T, Planutis K, Nguyen A, Marsh JL, Lin F, Hope C, Holcombe RF.

Int J Oncol. 2004 Nov;25(5):1337-42.

PMID:
15492823
11.

Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.

Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E, Prieto J, Qian C.

Cancer Res. 2009 Sep 1;69(17):6951-9. doi: 10.1158/0008-5472.CAN-09-0541. Epub 2009 Aug 18.

12.

Over expression of ID-1 in prostate cancer.

Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC.

J Urol. 2002 Jun;167(6):2598-602.

PMID:
11992094
13.

Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.

Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, Hermann K, Pilarsky C, Dürst M, Klinkhammer-Schalke M, Blaszyk H, Knuechel R, Hartmann A, Rosenthal A, Wild PJ.

Clin Cancer Res. 2006 Jul 1;12(13):3950-60.

14.

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.

Veeck J, Wild PJ, Fuchs T, Schüffler PJ, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Jul 1;9:217. doi: 10.1186/1471-2407-9-217.

15.

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer.

Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C, Hartmann A.

Lab Invest. 2004 Apr;84(4):465-78.

16.

Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.

Wikman H, Seppänen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, Nagy B, Karjalainen A, Sioris T, Salo J, Hollmén J, Knuutila S, Anttila S.

J Pathol. 2004 May;203(1):584-93.

PMID:
15095482
18.

Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.

Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.

Ann Thorac Surg. 2005 Jan;79(1):248-53.

PMID:
15620951
19.

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.

Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.

Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.

Supplemental Content

Support Center